No Data
No Data
Press Release: Eupraxia Pharmaceuticals Reports Second Quarter 2024 Financial Results
Eupraxia Pharmaceuticals to Present at Controlled Release Society 2024 Annual Meeting and Expo
Eupraxia Pharmaceuticals' CEO Dr. James Helliwell to Participate in Webinar Event, "Exploring the Rapid Rise of Osteoarthritis" on July 9, 2024
Eupraxia Pharmaceuticals Announces Voting Results From Annual General and Special Meeting of Shareholders
Eupraxia Pharmaceuticals Inc. Brief: Says To Present Data From the Phase 2 SPRINGBOARD Study in Osteoarthritis of the Knee at EULAR European Congress of Rheumatology 2024
Eupraxia Pharmaceuticals to Host Virtual KOL Event on EP-104GI Clinical Development Program for Eosinophilic Esophagitis ("EoE") on May 29, 2024